Features
-
Biologics, Proteins, Vaccines | Drug Development
Addressing the Need for Standards in Cell and Gene Therapy
Identifying and understanding the areas with the greatest need for standardization to help the cell and gene industry progress.Robert Shaw, Robert Shaw Executive Director, Standards Coordinating Body for Regenerative Medicine 06.07.21
-
APIs | Drug Development
Biocatalysis: An Indispensable Tool for API Synthesis
Biocatalytic processing offers a wealth of advantages and should be evaluated during early-stage drug development.Benzion Dolitzky, VP R&D, Wavelength Pharmaceuticals 06.07.21
-
Aseptic Processing | Facilities | Fill/Finish
CEO Spotlight: Patrick Haffey, Selkirk
The chief executive talks about entering the fill/finish space as a CMO startup and the company’s new aseptic fill/finish facility.Tim Wright, Editor, Contract Pharma 06.07.21
-
Clinical Trial Materials | Drug Development | Preclinical Outsourcing
Strategies for Entering Phase 1 Clinical Development with Limited API
Removing API supply as a criterion in the “Go/No-Go” decision tree and enhancing the opportunity to successfully navigate the pharmaceutical “Valley of Death.”Thomas Daggs and Angelo Consalvo, Enteris BioPharma 06.07.21
-
Drug Development | Preclinical Outsourcing
Preparing for Preclinical Testing: A Readiness Checklist
As companies prepare for preclinical testing, they can use this checklist to make sure they are ready.Mark Walker, Senior Technical Director of Toxicology, WuXi AppTec Laboratory Testing Division 06.07.21
-
Analytical Services | Bioanalytical Services | Drug Development | Laboratory Testing | R&D
CRO Industry Update
Digital modernization, decentralized trials and advanced therapies drive outsourcing.Kristin Brooks, Managing Editor, Contract Pharma 06.07.21
-
Biologics, Proteins, Vaccines | Clinical Trials
Gene Therapy Trials
Answering critical regulatory and study start-up questions for gene therapy trials in the U.S., UK, and Europe.April Marquick, Cell and Gene Therapy Expert, Premier Research 06.07.21
-
Logistics | Supply Chain
Flexible Supply Chain Development: The Engine of Decentralized Trials
Managing demands for increasingly complex clinical trial logistics.Gaurang Majmudar and Nina Vas, Marken 06.07.21
-
Clinical Trials
Waving Goodbye to Human Clinical Trials in a Post-COVID Landscape
Exploring the untapped potential presented by current biowaiver regulations.Jaleel Shujath and Rao Mukkavilli, Absorption Systems 06.07.21
-
CEO Spotlight: Todd R. Daviau, CoreRx
Following the recent investment from NovaQuest, CoreRx plans for the future.Kristin Brooks, Managing Editor, Contract Pharma 06.07.21
-
22nd Annual Salary Survey
Welcome to Contract Pharma’s 22nd Annual Salary & Job Satisfaction Survey!Tim Wright, Editor, Contract Pharma 06.07.21
-
Biologics, Proteins, Vaccines
Adapting Manufacturing for Super Small Batch, Precision Medicines
A look at how the sector can prepare the supply chain for the potentially disruptive trend of personalized medicines.Rod Schregardus, Business Development Manager, The Access Group 06.07.21
-
Facilities | Solid Dosage/Creams/Ointments
Newsmakers: Lynn Allen, Vice President of Business Development, MedPharm
Newly expanded labs bolster testing, formulation development, and manufacturing services.Tim Wright, Editor, Contract Pharma 06.03.21
-
Regulatory Affairs
Meeting with the FDA: Valuing the Statistician and Preparation for Review
A look at the key roles and responsibilities of FDA and biopharmaceutical industry statisticians throughout product lifespan.Joshua Baker, VP and LaRee Tracy, PHASTAR 05.27.21
-
CDMO Market Trends & Opportunities
CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.Tim Wright, Editor, Contract Pharma 05.05.21
-
Fast Track Automation in Pharmaceutical Manufacturing
Drug manufacturers turn to advanced automation technologies and project execution methodologies to reduce time, cost and risk.Steve Zarichniak, Technical Solutions Consultant, Honeywell Process Solutions 05.05.21
-
Are Your Suppliers Supporting Your Growth?
The role of strategic sourcing and procurement for emerging biopharmaceutical companies.Dave Stowe and Jonathan Horn, Tunnell Consulting 05.05.21
-
Small Molecule Drug Development Trends
Lonza’s Robert Beland discusses best practices for manufacturers to shorten development timelines, as well as some of the capabilities at the CDMO's Tampa site.Tim Wright, Editor, Contract Pharma 05.05.21
-
Analytical Services | Laboratory Testing
Dissolution Development
Fast track methodology for your highly soluble, highly permeable drug.Melissa Nelson and Caitlin White, Metrics Contract Services 05.05.21
-
CEO Spotlight: Tom Hochuli
Vibalogics’ recently appointed chief executive talks virotherapy trends, the COVID-19 pandemic and the company’s evolution as a CDMO.Tim Wright, Editor, Contract Pharma 05.05.21
